Larrayoz M - Search Results

1

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.

García-Barchino MJ, Sarasquete ME, Panizo C, Morscio J, Martinez A, Alcoceba M, Fresquet V, Gonzalez-Farre B, Paiva B, Young KH, Robles EF, Roa S, Celay J, Larrayoz M, Rossi D, Gaidano G, Montes-Moreno S, Piris MA, Balanzategui A, Jimenez C, Rodriguez I, Calasanz MJ, Larrayoz MJ, Segura V, Garcia-Muñoz R, Rabasa MP, Yi S, Li J, Zhang M, Xu-Monette ZY, Puig-Moron N, Orfao A, Böttcher S, Hernandez-Rivas JM, Miguel JS, Prosper F, Tousseyn T, Sagaert X, Gonzalez M, Martinez-Climent JA. García-Barchino MJ, et al. Among authors: larrayoz m, larrayoz mj. J Pathol. 2018 May;245(1):61-73. doi: 10.1002/path.5060. Epub 2018 Mar 30. J Pathol. 2018. PMID: 29464716

2

Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.

Agirre X, Vizmanos JL, Calasanz MJ, García-Delgado M, Larráyoz MJ, Novo FJ. Agirre X, et al. Among authors: larrayoz mj. Oncogene. 2003 Feb 20;22(7):1070-2. doi: 10.1038/sj.onc.1206236. Oncogene. 2003. PMID: 12592393

3

t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.

Vizmanos JL, Larráyoz MJ, Lahortiga I, Floristán F, Alvarez C, Odero MD, Novo FJ, Calasanz MJ. Vizmanos JL, et al. Genes Chromosomes Cancer. 2003 Apr;36(4):402-5. doi: 10.1002/gcc.10174. Genes Chromosomes Cancer. 2003. PMID: 12619164 Free article.

4

NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).

Lahortiga I, Vizmanos JL, Agirre X, Vázquez I, Cigudosa JC, Larrayoz MJ, Sala F, Gorosquieta A, Perez-Equiza K, Calasanz MJ, Odero MD. Lahortiga I, et al. Cancer Res. 2003 Jun 15;63(12):3079-83. Cancer Res. 2003. PMID: 12810632 Free article.

5

TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.

Agirre X, Novo FJ, Calasanz MJ, Larráyoz MJ, Lahortiga I, Valgañón M, García-Delgado M, Vizmanos JL. Agirre X, et al. Among authors: larrayoz mj. Mol Carcinog. 2003 Dec;38(4):201-8. doi: 10.1002/mc.10159. Mol Carcinog. 2003. PMID: 14639659

6

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.

Lahortiga I, Agirre X, Belloni E, Vázquez I, Larrayoz MJ, Gasparini P, Lo Coco F, Pelicci PG, Calasanz MJ, Odero MD. Lahortiga I, et al. Oncogene. 2004 Jan 8;23(1):311-6. doi: 10.1038/sj.onc.1206923. Oncogene. 2004. PMID: 14712237 Free article.

7

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.

Lahortiga I, Vázquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, Calasanz MJ, Odero MD. Lahortiga I, et al. Genes Chromosomes Cancer. 2004 Jul;40(3):179-89. doi: 10.1002/gcc.20033. Genes Chromosomes Cancer. 2004. PMID: 15138998 Free article.

8

Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.

Vizmanos JL, Hernández R, Vidal MJ, Larráyoz MJ, Odero MD, Marín J, Ardanaz MT, Calasanz MJ, Cross NC. Vizmanos JL, et al. Hematol J. 2004;5(6):534-7. doi: 10.1038/sj.thj.6200561. Hematol J. 2004. PMID: 15570299

9

p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.

Valgañón M, Giraldo P, Agirre X, Larráyoz MJ, Rubio-Martinez A, Rubio-Felix D, Calasanz MJ, Odero MD. Valgañón M, et al. Among authors: larrayoz mj. Br J Haematol. 2005 Apr;129(1):53-9. doi: 10.1111/j.1365-2141.2005.05405.x. Br J Haematol. 2005. PMID: 15801955 Free article.

10

Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.

Agirre X, Román-Gómez J, Vázquez I, Jiménez-Velasco A, Larráyoz MJ, Lahortiga I, Andreu EJ, Márquez J, Beltrán de Heredia JM, Odero MD, Prósper F, Calasanz MJ. Agirre X, et al. Among authors: larrayoz mj. Cancer Genet Cytogenet. 2005 Jul 1;160(1):22-6. doi: 10.1016/j.cancergencyto.2004.11.010. Cancer Genet Cytogenet. 2005. PMID: 15949566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters